These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34369341)

  • 1. Psychoendocrinology: arginine vasopressin and resilience in patients with major depressive disorder.
    Abdel Mawella SM; Hussein HA; Zyada F; Abdelaal A; Ayoub DR; Naguy A
    CNS Spectr; 2023 Feb; 28(1):41-45. PubMed ID: 34369341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
    Scott LV; Dinan TG
    Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor.
    DeBold CR; Sheldon WR; DeCherney GS; Jackson RV; Alexander AN; Vale W; Rivier J; Orth DN
    J Clin Invest; 1984 Feb; 73(2):533-8. PubMed ID: 6321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.
    Poretti MB; Sawant RS; Rask-Andersen M; de Cuneo MF; Schiöth HB; Perez MF; Carlini VP
    Psychopharmacology (Berl); 2016 Mar; 233(6):1077-86. PubMed ID: 26700241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
    Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
    Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans.
    Arvat E; Maccagno B; Ramunni J; Di Vito L; Broglio F; Deghenghi R; Camanni F; Ghigo E
    Neuroendocrinology; 1997 Dec; 66(6):432-8. PubMed ID: 9430449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder.
    de Kloet CS; Vermetten E; Geuze E; Wiegant VM; Westenberg HG
    J Psychiatr Res; 2008 Feb; 42(3):192-8. PubMed ID: 17222428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histamine- and stress-induced secretion of ACTH and beta-endorphin: involvement of corticotropin-releasing hormone and vasopressin.
    Kjaer A; Knigge U; Bach FW; Warberg J
    Neuroendocrinology; 1992 Sep; 56(3):419-28. PubMed ID: 1331840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G; Ansseau M; Legros JJ
    Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of arginine vasopressin in control of ACTH and LH release during stress.
    Ono N; Bedran de Castro J; Khorram O; McCann SM
    Life Sci; 1985 May; 36(18):1779-86. PubMed ID: 2984509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion.
    Kalogeras KT; Nieman LK; Friedman TC; Doppman JL; Cutler GB; Chrousos GP; Wilder RL; Gold PW; Yanovski JA
    J Clin Invest; 1996 May; 97(9):2045-50. PubMed ID: 8621793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprazolam attenuates vasopressin-stimulated adrenocorticotropin and cortisol release: evidence for synergy between vasopressin and corticotropin-releasing hormone in humans.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1994 Jul; 79(1):140-4. PubMed ID: 8027217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changes in, and relationship between, plasma nitric oxide and corticotropin-releasing hormone in patients with major depressive disorder.
    Lu YR; Zhang Y; Rao YB; Chen X; Lou HF; Zhang Y; Xie HY; Fang P; Hu LW
    Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):10-15. PubMed ID: 28755509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of arginine vasopressin elevated in patients with major depression.
    van Londen L; Goekoop JG; van Kempen GM; Frankhuijzen-Sierevogel AC; Wiegant VM; van der Velde EA; De Wied D
    Neuropsychopharmacology; 1997 Oct; 17(4):284-92. PubMed ID: 9326754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the nature of the interaction between vasopressin and corticotropin-releasing factor on adrenocorticotropin release in the rat.
    Rivier C; Rivier J; Mormede P; Vale W
    Endocrinology; 1984 Sep; 115(3):882-6. PubMed ID: 6086290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G; DeBold CR; Gaitan D; DeCherney GS; Jackson RV; Sheldon WR; Nicholson WE; Orth DN
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2934-41. PubMed ID: 8768855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A synergistic adrenocorticotropin response to naloxone and vasopressin in normal humans: evidence that naloxone stimulates endogenous corticotropin-releasing hormone.
    Hockings GI; Grice JE; Walters MM; Crosbie GV; Torpy DJ; Jackson RV
    Neuroendocrinology; 1995 Feb; 61(2):198-206. PubMed ID: 7753339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vasopressin in the nicotine-induced stimulation of ACTH and cortisol in men.
    Stalke J; Hader O; Bähr V; Hensen J; Scherer G; Oelkers W
    Clin Investig; 1992; 70(3-4):218-23. PubMed ID: 1325853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin levels in Cushing's disease: inferior petrosal sinus assay, response to corticotrophin-releasing hormone and comparison with patients without Cushing's disease.
    Colao A; Ferone D; Di Sarno A; Tripodi FS; Cerbone G; Marzullo P; Boudouresque F; Oliver C; Merola B; Lombardi G
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):157-66. PubMed ID: 8881447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.